Provenge

1 Story

FDA Panel Passes First Cancer Vaccine

Prostate treatment recruits immune system to fight tumors

(Newser) - A cancer drug that's the first to harness the body's immune system to destroy tumors got a thumbs-up from  the FDA's advisory panel, the New York Times reports. If approved, Provenge, a prostate cancer treatment, would be the first of the "cancer vaccines"—experimental therapies that commandeer a... More »

1 Story

AROUND THE WEB